Although CIP is more frequently observed with PD-1/PD-L1 blockades than with CTLA-4 blockades (102), CIP has not yet become a symbolic irAE of anti–PD-1/PD-L1 antibodies. This evidence concerns the gene CTLA4 and hereditary sensory and autonomic neuropathy.